Mangoceuticals, Inc.
General ticker "MGRX" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $13.2M (TTM average)
Mangoceuticals, Inc. does not follow the US Stock Market performance with the rate: -24.9%.
Estimated limits based on current volatility of 6.4%: low 0.42$, high 0.48$
Factors to consider:
- Total employees count: 750 as of 2023
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Financing risks, FDA approval delays, Growth execution, Pandemic risks, Market competition
- Current price 29.1% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.54$, 1.70$]
- 2026-12-31 to 2027-12-31 estimated range: [0.43$, 1.35$]
Financial Metrics affecting the MGRX estimates:
- Positive: with PPE of -0.3 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -79.75 <= 0.30
- Positive: Investing cash flow per share per price, % of 0 > -0.65
- Positive: Interest expense per share per price, % of 1.41 <= 3.33
- Positive: Shareholder equity ratio, % of 94.47 > 63.79
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Net income
Short-term MGRX quotes
Long-term MGRX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.73MM | $0.62MM | $0.46MM |
| Operating Expenses | $9.95MM | $8.59MM | $19.61MM |
| Operating Income | $-9.22MM | $-7.97MM | $-19.15MM |
| Non-Operating Income | $0.01MM | $-0.74MM | $-1.49MM |
| Interest Expense | $0.00MM | $0.01MM | $0.10MM |
| Income(Loss) | $-9.21MM | $-8.71MM | $-20.64MM |
| Net Income(Loss)* | $-9.21MM | $-8.71MM | $-20.64MM |
| Stockholders Equity | $0.77MM | $13.95MM | $15.20MM |
| Inventory | $0.02MM | $0.00MM | $0.00MM |
| Assets | $1.05MM | $15.37MM | $16.09MM |
| Operating Cash Flow | $-7.00MM | $-4.86MM | $-5.85MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.00MM | $0.07MM | $0.00MM |
| Financing Cash Flow | $7.06MM | $4.13MM | $7.27MM |
| Earnings Per Share** | $-8.58 | $-4.40 | $-2.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.